Skip to main content
Back to feed
MarketsUnknownLow
2.0

Archimed acquires control of Brazilian biotech Genetica Bioscience

Archimed, a European impact manager with €8B in assets, acquired control of Genetica Bioscience, a Brazilian biotech founded 23 years ago in Chapecó. The deal signals continued private-equity interest in Latin American industrial biotech, though financial terms were not disclosed.

Brazil Journalabout 17 hours agoBR, FRCredibility 36%View source

Score Breakdown

Mosaic Score2.0
Model confidence0.5
Significance0.1
Source credibility0.4

Intelligence Tags

#biotech#private-equity#impact-investing#mergers-acquisitions#industrial-biotech

Locations

ChapecóBrazil

Entities

countrycountrycountry
Source

Related signals

8 found